EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cerebral Amyloid Angiopathy

Steven M Greenberg iD

New England Journal of Medicine · 07.05.2026 · 394 (18) · 1836-1845

DOI: 10.1056/nejmra2411298 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 07.05.2026. Verfasst von Steven M Greenberg. Beteiligte Einrichtung: J. Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Cognitive Dysfunction, Hemorrhagic Stroke. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral amyloid angiopathy is a major cause of hemorrhagic stroke, a frequent contributor to age-related cognitive impairment, and a key component in adverse responses to beta-amyloid (Aβ) immunotherapy. Defined by pathological deposition of Aβ in the small blood vessels of the brain, cerebral amyloid angiopathy is most often diagnosed on the basis of magnetic resonance imaging studies showing multiple hemorrhages or leptomeningeal blood products within or overlying the cerebral cortex. The disorder typically manifests as hemorrhagic stroke or as a contributing factor to cognitive decline and, less commonly, with transient focal neurologic symptoms or a cerebral inflammatory autoimmune syndrome. The high risk of recurrent hemorrhagic strokes associated with cerebral amyloid angiopathy poses a particular challenge in patients with indications for antithrombotic therapy and dictates a carefully individualized weighing of risks and benefits. Ongoing research is focused on tools to aid in risk prediction, early diagnostic markers, and identification of key pathogenic steps as targets for disease-modifying therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Amyloid AngiopathyCognitive DysfunctionHemorrhagic StrokeHumansAmyloid beta-PeptidesBrainMagnetic Resonance ImagingEarly DiagnosisRisk AssessmentRisk FactorsAge FactorsNeuroimagingPositron-Emission TomographyPrevalence

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • J. Philip Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Boston.
  • Harvard Medical School, Boston.

ORCID-Profile: Steven M Greenberg

Zitieren

APA

Greenberg, S. M. (2026). Cerebral Amyloid Angiopathy. New England Journal of Medicine, 394(18), 1836-1845. https://doi.org/10.1056/nejmra2411298

Vancouver

Greenberg SM. Cerebral Amyloid Angiopathy. New England Journal of Medicine. 2026;394(18):1836-1845. doi:10.1056/nejmra2411298

BibTeX
@article{Greenberg2026,
  author = {Greenberg, Steven M},
  title = {Cerebral Amyloid Angiopathy},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {18},
  pages = {1836--1845},
  doi = {10.1056/nejmra2411298}
}
Kostenlos starten →